Press Releases
FDA’s Decision Forthcoming for Innovative Test with Agency’s Breakthrough Device Designation ST. LOUIS, Jan. 24, 2023 / — Geneoscopy, Inc., a life sciences company focused
Colorectal Cancer and Advanced Adenoma Sensitivity Results are the Highest Reported from any Prospective Pivotal Study for a Noninvasive Screening Test Innovative RNA Biomarker Screening
New look matches focus on transforming GI health ST. LOUIS, MISSOURI (October 3, 2022) | Geneoscopy today announced a corporate rebrand and launch. The rebranding
Trial Enrollment Over Indexes in Traditionally Under-Represented Black Community ST. LOUIS, Aug. 23, 2022 /PRNewswire/ — Geneoscopy Inc., a life sciences company focused on the development of diagnostic tests
ST. LOUIS, MISSOURI (JULY 19, 2022) | Earlier this year, President Joe Biden announced plans to reignite the Cancer Moonshot with renewed leadership and new ambitious
ST. LOUIS, June 21, 2022 /PRNewswire/ — Geneoscopy Inc., a life sciences company focused on the development of diagnostic tests for gastrointestinal (GI) health, today announced the formation of
News & Stories
Adds CAP Accreditation to Clinical Laboratory Improvement Amendments (CLIA) certification ST. LOUIS, Dec. 14, 2022 / — Geneoscopy, Inc., a life sciences company focused on
Originally published July 1, 2022 Haytham Gareer, MD, PhD, MBA, FACS for Pharmacy Times Nearly 63% of newly diagnosed patients have advanced colorectal cancer,
Podcasts & Videos
- Video | August 19, 2022
- Video | July 27, 2022
- Video | January 25, 2022
- Podcast | August 14, 2022
- Podcast | July 23, 2022
- Podcast | January 25, 2022
Abstracts
